{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:42:17Z","timestamp":1774370537286,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K08AI130381"],"award-info":[{"award-number":["K08AI130381"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 142790-S1"],"award-info":[{"award-number":["U19 142790-S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-006133"],"award-info":[{"award-number":["INV-006133"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Successful control of the COVID-19 pandemic depends on vaccines that prevent transmission. The full-length Spike protein is highly immunogenic but the majority of antibodies do not target the virus: ACE2 interface. In an effort to affect the quality of the antibody response focusing it to the receptor-binding motif (RBM) we generated a series of conformationally-constrained immunogens by inserting solvent-exposed RBM amino acid residues into hypervariable loops of an immunoglobulin molecule. Priming C57BL\/6 mice with plasmid (p)DNA encoding these constructs yielded a rapid memory response to booster immunization with recombinant Spike protein. Immune sera antibodies bound strongly to the purified receptor-binding domain (RBD) and Spike proteins. pDNA primed for a consistent response with antibodies efficient at neutralizing authentic WA1 virus and three variants of concern (VOC), B.1.351, B.1.617.2, and BA.1. We demonstrate that immunogens built on structure selection can be used to influence the quality of the antibody response by focusing it to a conserved site of vulnerability shared between wildtype virus and VOCs, resulting in neutralizing antibodies across variants.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010686","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T14:00:21Z","timestamp":1658412021000},"page":"e1010686","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern"],"prefix":"10.1371","volume":"18","author":[{"given":"Gonzalo","family":"Almanza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Kouznetsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Olmedillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor F.","family":"Tsigelny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra L.","family":"Leibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Ollmann Saphire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron F.","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-8776","authenticated-orcid":true,"given":"Maurizio","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"key":"ppat.1010686.ref001","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): A review","volume":"78","author":"M Nicola","year":"2020","journal-title":"Int J Surg"},{"issue":"7","key":"ppat.1010686.ref002","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"ppat.1010686.ref003","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"S Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"10","key":"ppat.1010686.ref004","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"MD de Jong","year":"2006","journal-title":"Nat Med"},{"issue":"3","key":"ppat.1010686.ref005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2016.02.010","article-title":"Complex Antigens Drive Permissive Clonal Selection in Germinal Centers","volume":"44","author":"M Kuraoka","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"ppat.1010686.ref006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/vim.2017.0129","article-title":"Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift","volume":"31","author":"MO Altman","year":"2018","journal-title":"Viral Immunol"},{"issue":"5","key":"ppat.1010686.ref007","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance","volume":"177","author":"KM Cirelli","year":"2019","journal-title":"Cell"},{"issue":"2","key":"ppat.1010686.ref008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","article-title":"Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019","volume":"222","author":"PD Burbelo","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1010686.ref009","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1038\/s41598-018-33087-6","article-title":"IgG-mediated immune suppression in mice is epitope specific except during high epitope density conditions","volume":"8","author":"H Xu","year":"2018","journal-title":"Sci Rep"},{"issue":"7821","key":"ppat.1010686.ref010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","article-title":"A perspective on potential antibody-dependent enhancement of SARS-CoV-2","volume":"584","author":"AM Arvin","year":"2020","journal-title":"Nature"},{"issue":"6585","key":"ppat.1010686.ref011","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.abn1755","article-title":"COVID-19 vaccination: The road ahead","volume":"375","author":"DM Altmann","year":"2022","journal-title":"Science"},{"issue":"7807","key":"ppat.1010686.ref012","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"J Lan","year":"2020","journal-title":"Nature"},{"issue":"5","key":"ppat.1010686.ref013","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding","volume":"182","author":"TN Starr","year":"2020","journal-title":"Cell"},{"issue":"6496","key":"ppat.1010686.ref014","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Y Wu","year":"2020","journal-title":"Science"},{"issue":"7819","key":"ppat.1010686.ref015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"R Shi","year":"2020","journal-title":"Nature"},{"issue":"6506","key":"ppat.1010686.ref016","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"TF Rogers","year":"2020","journal-title":"Science"},{"issue":"4","key":"ppat.1010686.ref017","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","volume":"182","author":"CO Barnes","year":"2020","journal-title":"Cell"},{"issue":"7821","key":"ppat.1010686.ref018","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"SJ Zost","year":"2020","journal-title":"Nature"},{"issue":"7821","key":"ppat.1010686.ref019","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"L Liu","year":"2020","journal-title":"Nature"},{"issue":"7815","key":"ppat.1010686.ref020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"D Pinto","year":"2020","journal-title":"Nature"},{"issue":"6519","key":"ppat.1010686.ref021","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"MA Tortorici","year":"2020","journal-title":"Science"},{"issue":"6546","key":"ppat.1010686.ref022","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.abg5268","article-title":"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes","volume":"372","author":"WN Voss","year":"2021","journal-title":"Science"},{"issue":"10","key":"ppat.1010686.ref023","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf2467","article-title":"Longitudinal antibody repertoire in \"mild\" versus \"severe\" COVID-19 patients reveals immune markers associated with disease severity and resolution","volume":"7","author":"S Ravichandran","year":"2021","journal-title":"Sci Adv"},{"issue":"6504","key":"ppat.1010686.ref024","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"X Chi","year":"2020","journal-title":"Science"},{"issue":"6491","key":"ppat.1010686.ref025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"M Yuan","year":"2020","journal-title":"Science"},{"issue":"6510","key":"ppat.1010686.ref026","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Z Lv","year":"2020","journal-title":"Science"},{"issue":"8","key":"ppat.1010686.ref027","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","volume":"184","author":"W Dejnirattisai","year":"2021","journal-title":"Cell"},{"issue":"7839","key":"ppat.1010686.ref028","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"CO Barnes","year":"2020","journal-title":"Nature"},{"key":"ppat.1010686.ref029","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/355476a0","article-title":"Antigenized antibodies","volume":"355","author":"M. Zanetti","year":"1992","journal-title":"Nature"},{"key":"ppat.1010686.ref030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.132.2.211","volume":"132","author":"TT Wu","year":"1970","journal-title":"J Exp Med"},{"key":"ppat.1010686.ref031","first-page":"75","volume-title":"In \"The Antibodies\"","author":"M Zanetti","year":"1996"},{"issue":"12","key":"ppat.1010686.ref032","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/eji.1830191209","article-title":"Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells","volume":"19","author":"BP Panina","year":"1989","journal-title":"Eur J Immunol"},{"key":"ppat.1010686.ref033","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0105-2896.2004.00152.x","article-title":"B lymphocytes as antigen-presenting cell-based genetic vaccines","volume":"199","author":"M Zanetti","year":"2004","journal-title":"Immunol Rev"},{"issue":"9","key":"ppat.1010686.ref034","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nbt0997-876","article-title":"Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization","volume":"15","author":"M Gerloni","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"2","key":"ppat.1010686.ref035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<516::AID-IMMU516>3.0.CO;2-M","article-title":"DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgM\u2014>IgG1 switch in vivo","volume":"28","author":"M Gerloni","year":"1998","journal-title":"Eur J Immunol"},{"key":"ppat.1010686.ref036","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Y Weisblum","year":"2020","journal-title":"Elife"},{"issue":"9","key":"ppat.1010686.ref037","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"WF Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"7857","key":"ppat.1010686.ref038","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"P Wang","year":"2021","journal-title":"Nature"},{"issue":"6556","key":"ppat.1010686.ref039","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.abh1139","article-title":"Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants","volume":"373","author":"M Yuan","year":"2021","journal-title":"Science"},{"issue":"6556","key":"ppat.1010686.ref040","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh1766","article-title":"Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants","volume":"373","author":"L Wang","year":"2021","journal-title":"Science"},{"issue":"7874","key":"ppat.1010686.ref041","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"TN Starr","year":"2021","journal-title":"Nature"},{"issue":"6579","key":"ppat.1010686.ref042","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.abm8143","article-title":"Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry","volume":"375","author":"YJ Park","year":"2022","journal-title":"Science"},{"issue":"24","key":"ppat.1010686.ref043","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMc2103740","article-title":"Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351","volume":"384","author":"X Shen","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"ppat.1010686.ref044","article-title":"SARS-CoV-2 spike E484K mutation reduces antibody neutralisation","author":"Personalized Virology Initiative study g","year":"2021","journal-title":"Lancet Microbe"},{"issue":"15","key":"ppat.1010686.ref045","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing Activity of BNT162b2-Elicited Serum","volume":"384","author":"Y Liu","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"ppat.1010686.ref046","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMc2102179","article-title":"Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine","volume":"384","author":"K Wu","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"7857","key":"ppat.1010686.ref047","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma","volume":"593","author":"S Cele","year":"2021","journal-title":"Nature"},{"issue":"7857","key":"ppat.1010686.ref048","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","article-title":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies","volume":"593","author":"DA Collier","year":"2021","journal-title":"Nature"},{"issue":"6578","key":"ppat.1010686.ref049","doi-asserted-by":"crossref","first-page":"eabl6251","DOI":"10.1126\/science.abl6251","article-title":"Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain","volume":"375","author":"KG Nabel","year":"2022","journal-title":"Science"},{"issue":"6582","key":"ppat.1010686.ref050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex","volume":"375","author":"D Mannar","year":"2022","journal-title":"Science"},{"issue":"6","key":"ppat.1010686.ref051","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma Neutralization of the SARS-CoV-2 Omicron Variant","volume":"386","author":"F Schmidt","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ppat.1010686.ref052","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","article-title":"Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19","volume":"26","author":"JA Juno","year":"2020","journal-title":"Nat Med"},{"issue":"570","key":"ppat.1010686.ref053","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Y Zuo","year":"2020","journal-title":"Sci Transl Med"},{"issue":"6515","key":"ppat.1010686.ref054","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"P Bastard","year":"2020","journal-title":"Science"},{"key":"ppat.1010686.ref055","article-title":"Autoimmunity to the Lung Protective Phospholipid-Binding Protein Annexin A2 Predicts Mortality Among Hospitalized COVID-19 Patients","author":"M Zuniga","year":"2021","journal-title":"medRxiv"},{"key":"ppat.1010686.ref056","unstructured":"Agrawal G, Holt T, Suresh B, Chir W, Van der Veken L. The COVID-19 vaccines are here: What comes next?."},{"issue":"10282","key":"ppat.1010686.ref057","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(21)00526-2","article-title":"The unsung virtue of thermostability","volume":"397","author":"I Capua","year":"2021","journal-title":"Lancet"},{"key":"ppat.1010686.ref058","article-title":"Scaling Up Covid-19 Vaccination in Africa\u2014Lessons from the HIV Pandemic","author":"JB Nachega","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"ppat.1010686.ref059","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nbt0997-882","article-title":"Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes","volume":"15","author":"S Xiong","year":"1997","journal-title":"Nature Biotech"},{"issue":"3","key":"ppat.1010686.ref060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/eji.1830190307","article-title":"Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB\/c mice","volume":"19","author":"M Sollazzo","year":"1989","journal-title":"Eur J Immunol"},{"issue":"8","key":"ppat.1010686.ref061","doi-asserted-by":"crossref","first-page":"e1000478","DOI":"10.1371\/journal.pcbi.1000478","article-title":"A self-organizing algorithm for modeling protein loops","volume":"5","author":"P Liu","year":"2009","journal-title":"PLoS Comput Biol"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1013707","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T14:01:24Z","timestamp":1658412084000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010686"}},"subtitle":[],"editor":[{"given":"Charles R. M.","family":"Bangham","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010686","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.01.462840","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]}}}